Correlation Between Toyo Suisan and Integrated Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Toyo Suisan and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Toyo Suisan and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Toyo Suisan Kaisha and Integrated Biopharma, you can compare the effects of market volatilities on Toyo Suisan and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Toyo Suisan with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Toyo Suisan and Integrated Biopharma.

Diversification Opportunities for Toyo Suisan and Integrated Biopharma

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between Toyo and Integrated is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Toyo Suisan Kaisha and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Toyo Suisan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Toyo Suisan Kaisha are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Toyo Suisan i.e., Toyo Suisan and Integrated Biopharma go up and down completely randomly.

Pair Corralation between Toyo Suisan and Integrated Biopharma

If you would invest  33.00  in Integrated Biopharma on August 29, 2024 and sell it today you would earn a total of  0.00  from holding Integrated Biopharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Toyo Suisan Kaisha  vs.  Integrated Biopharma

 Performance 
       Timeline  
Toyo Suisan Kaisha 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Toyo Suisan Kaisha has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking signals, Toyo Suisan is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Integrated Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Toyo Suisan and Integrated Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Toyo Suisan and Integrated Biopharma

The main advantage of trading using opposite Toyo Suisan and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Toyo Suisan position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.
The idea behind Toyo Suisan Kaisha and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format